Fauci not disappointed by FDA advisory panel's COVID-19 booster recommendation

Dr. Anthony Fauci, the nation's top infectious disease expert, said Sunday he's "not necessarily at all" disappointed by the Food and Drug Administration's advisory panel's decision to not recommend COVID-19 vaccine boosters for all Americans.
The advisory panel, which was only looking at data for the Pfizer-BioNTech vaccine, overwhelmingly opted against an additional shot for everyone, and instead approved a third dose for people over 65 or individuals who are at high risk of developing severe COVID-19 infections, either because of underlying health conditions or the nature of their jobs.
Fauci, who backed the White House's push to roll out boosters, noted that "we had said right from the beginning that this would be contingent upon the examination of all of the data that the FDA accumulated that would be discussed with their advisory committee, and that's exactly what happened." At the end of the day, he told ABC News' Martha Raddatz, "I think the process worked."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
FIRE is catching as people want to leave the traditional workforce
In the spotlight Many are taking steps to retire early
-
How might Bari Weiss change CBS News?
Talking Points Is the network trying to ‘appease’ the president?
-
‘A legacy news brand brings a visibility of its own’
Instant Opinion Opinion, comment and editorials of the day
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
Why are autism rates increasing?
The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Cytomegalovirus can cause permanent birth defects
The Explainer The virus can show no symptoms in adults
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system